About Chugai
Chugai's mission is to create innovative drugs
for the benefit of patients.
News ReleasesRSS
- Jun 18, 2019 Anti-Cancer Agent Rozlytrek, Approved for the Treatment of NTRK Fusion Gene Positive Advanced/Recurrent Solid Tumors
- Jun 14, 2019 Chugai and Mitsubishi Logistics Enter into Service Agreement for Logistics Operations
- Jun 03, 2019 Chugai Files for Additional Indication of ALK Inhibitor ALECENSA for Recurrent or Refractory ALK Fusion Gene-Positive Anaplastic Large Cell Lymphoma (ALCL)
- Jun 03, 2019 Chugai Launches Genomic Mutation Analysis Program, FoundationOne CDx Cancer Genomic Profile
- Jun 03, 2019 Final Progression-Free Survival Data and the Second Interim Analysis of Overall Survival from the J-ALEX Study for Alecensa Presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Diversity and Inclusion Initiatives
Find information on our initiatives to promote work-life balance and diverse human resources, and performance data for topics such as the ratio of female employees.
-
Engagement with Employees
Chugai promotes engagement with employees by conducting talent management according to each person's capabilities and aptitude, providing systems that help our diverse people to succeed, and creating supportive work environments.
For more information
Feature: Chugai’s Sustainability Activities
Recent Social Contribution Activities
-
Biology Lab Classes for Children Held (2018)
-
Participating in the 48th Annual Cleaning of the Famed Nihonbashi Bridge
-
Chugai to Take Part in Relay for Life Japan 2018
